Ocuphire Pharma Retained Earnings (Accumulated Deficit) 2010-2024 | IRD
Ocuphire Pharma retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Ocuphire Pharma Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-81 |
| 2022 | $-71 |
| 2021 | $-89 |
| 2020 | $-33 |
| 2019 | $-8 |
| 2018 | $-155 |
| 2017 | $-140 |
| 2016 | $-115 |
| 2015 | $-106 |
| 2014 | $-91 |
| 2013 | $-73 |
| 2012 | $-63 |
| 2011 | $-57 |
| 2010 | $-46 |
| 2009 | $-32 |
| Ocuphire Pharma Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-96 |
| 2024-03-31 | $-89 |
| 2023-12-31 | $-81 |
| 2023-09-30 | $-77 |
| 2023-06-30 | $-82 |
| 2023-03-31 | $-77 |
| 2022-12-31 | $-71 |
| 2022-09-30 | $-105 |
| 2022-06-30 | $-101 |
| 2022-03-31 | $-96 |
| 2021-12-31 | $-89 |
| 2021-09-30 | $-83 |
| 2021-06-30 | $-79 |
| 2021-03-31 | $-72 |
| 2020-12-31 | $-33 |
| 2020-09-30 | $-168 |
| 2020-06-30 | $-166 |
| 2020-03-31 | $-164 |
| 2019-12-31 | $-8 |
| 2019-09-30 | $-161 |
| 2019-06-30 | $-159 |
| 2019-03-31 | $-157 |
| 2018-12-31 | $-155 |
| 2018-09-30 | $-152 |
| 2018-06-30 | $-146 |
| 2018-03-31 | $-142 |
| 2017-12-31 | $-140 |
| 2017-09-30 | $-137 |
| 2017-06-30 | $-136 |
| 2017-03-31 | $-137 |
| 2016-12-31 | $-115 |
| 2016-09-30 | $-114 |
| 2016-06-30 | $-112 |
| 2016-03-31 | $-110 |
| 2015-12-31 | $-106 |
| 2015-09-30 | $-103 |
| 2015-06-30 | $-99 |
| 2015-03-31 | $-96 |
| 2014-12-31 | $-91 |
| 2014-09-30 | $-89 |
| 2014-06-30 | $-87 |
| 2014-03-31 | $-87 |
| 2013-12-31 | $-73 |
| 2013-09-30 | $-70 |
| 2013-06-30 | $-68 |
| 2013-03-31 | $-65 |
| 2012-12-31 | $-63 |
| 2012-09-30 | $-63 |
| 2012-06-30 | |
| 2012-03-31 | $-59 |
| 2011-12-31 | $-57 |
| 2011-09-30 | $-57 |
| 2011-06-30 | $-56 |
| 2011-03-31 | $-50 |
| 2010-12-31 | $-46 |
| 2010-09-30 | $-43 |
| 2010-06-30 | $-41 |
| 2010-03-31 | $-38 |
| 2009-12-31 | $-32 |
| 2009-09-30 | $-34 |
| 2009-06-30 | $-33 |
| 2009-03-31 | $-31 |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fanhua (AIFU) | China | $0.086B | 2.07 |
| Top KingWin (WAI) | China | $0.008B | 0.00 |
| S&W Seed (SANW) | United States | $0.006B | 0.00 |
| Invo BioScience (NAYA) | United States | $0.004B | 0.00 |